Valproic acid-d15 is used in research on epilepsy, bipolar disorder, and migraine; it acts as an HDAC inhibitor (IC50: 0.5–2 mM), inhibits HDAC1 activity (IC50: 400 μM), induces HDAC2 degradation, activates Notch1 signaling, and suppresses proliferation of small cell lung cancer (SCLC) cells.